With Abomics’ pharmacogenetic interpretation service, the laboratory provides a report intended for physicians directly to the patient information system. This report includes individualized patient-specific recommendations for the selection and dosing of over 100 medications that are clinically significantly influenced by pharmacogenetics.
The pharmacogenetic test, which includes an interpretation report, is available from laboratories under the code B-Farma-D or B-FarmL-D.
Abomics and Multirec offer up-to-date medical databases to support doctors’ mediation decision-making. We update the databases according to regulatory requirements, and they can be adapted and integrated according to the needs of the customer.
Abomics, Abomics PGx, GeneRx, GeneAccount are registered or non-registered trademarks of Abomics Oy in various countries.
